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Abstract  
Background: The main focus of studies of individuals at ultra-high risk for psychosis (UHR) 
has been on identifying brain changes in those individuals who will develop psychosis. 
However, longitudinal studies have shown that up to half of UHR individuals are resilient, 
with symptomatic remission and good functioning at follow-up. Yet little is known about 
brain development in resilient individuals. Therefore, the aim of this study was to investigate 
differences in brain development between resilient and non-resilient individuals. 
Methods: A six-year longitudinal structural MRI study was performed with up to three scans 
per individual. The final sample consisted of 48 UHR individuals and 48 typically developing 
controls with a total of 225 MRI-scans, aged 12-20 years at the time of the first MRI-scan and 
matched for age, gender and number of follow-up scans. At six-year follow-up, 35 UHR 
individuals were divided in resilient (good functional outcome) and non-resilient (poor 
functional outcome) subgroups, defined by the modified Global Assessment of Functioning. 
The main outcome measures were developmental changes in MR-based measures of cortical 
and subcortical anatomy. 
Results: We found widespread differences in volume of frontal, temporal and parietal cortex 
between resilient and non-resilient individuals. These were already present at baseline and 
remained stable over development (12-24 years). Furthermore, there were differences in 
the development of cortical surface area in frontal regions including cingulate gyrus. 
Conclusions: Developmental differences may reflect compensatory neural mechanisms, 
where better functioning in resilient individuals leads to less tissue loss over development. 
Keywords: ultra-high risk, psychosis, resilience, MRI, functional outcome, brain development 
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1. Introduction  
Traditionally, studies of individuals at ultra-high risk (UHR) for psychosis have attempted to 
identify neurobiological markers to predict which UHR individuals will go on to develop 
psychosis (i.e. undergo a ‘transition to psychosis’). Thus, the field has focused on identifying 
differences in the brains of those subjects who will worsen over time compared to those 
who will not. However, transition rates have plummeted since the earliest reports of rates of 
over 50% (Miller et al. 2002) to an average of 29% in more recent reports (Fusar-Poli et al. 
2012a). At the same time, there has been a steady increase in the remission rates reported, 
of up to 54% (Simon et al. 2011). A recent meta-analysis of eight longitudinal studies (Simon 
et al. 2013) reported that 73% of 773 UHR subjects did not develop psychosis over a 2-year 
follow-up and 46% fully remitted from their baseline symptoms. We conducted a longer 
follow-up, with a mean of six years, and found that 41% of adolescents at UHR fully remitted 
from their at-risk state (de Wit et al. 2014). Therefore, it is at least as relevant to investigate 
neurobiological changes in UHR subjects who show resilience and go on to function well, as 
it is to investigate those who undergo a transition to psychosis.   
In addition, the criterion of ‘transition to psychosis’ has been criticized as a measure to 
identify which individuals will have a truly poor clinical outcome:  the threshold for transition 
is essentially arbitrary and is based entirely on positive symptoms (Fusar-Poli et al. 2013; 
Ziermans et al. 2014). There is increasing evidence that negative symptoms and the level of 
cognitive and social functioning are equally important for the long-term outcome of UHR 
individuals (Fusar-Poli & Borgwardt 2007; Carrión et al. 2013; Fusar-Poli et al. 2013). 
Moreover, some individuals may develop psychosis before going on to recover completely, 
while some individuals who do not develop psychosis may have worse outcomes (Yung et al. 
2010; Fusar-Poli & Van Os 2013; Cotter et al. 2014; de Wit et al. 2014). Taken together, this 
underscores the importance of studying resilience, as much as transition to psychosis. We 
follow the American Psychological Associate in defining resilience as “the process of 
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adapting well in the face of adversity, trauma, tragedy, threats or significant sources of 
stress — such as family and relationship problems, serious health problems or workplace and 
financial stressors. It means "bouncing back" from difficult experiences.” We therefore focus 
on how well individuals function at follow-up, rather than whether they have experienced a 
transition to psychosis and operationalise resilience as having good functional outcome. To 
permit comparison to the extant literature, we also perform complementary analyses using 
the more traditional operationalisation based on remission of positive symptoms (included 
as supplemental material).   
  
Compared to a volunteer sample of typically developing controls, UHR individuals have been 
reported to show reduced grey matter volume in the frontal and temporal lobes, anterior 
cingulate gyrus and hippocampal regions. (for reviews, see Fusar-Poli et al. 2011; Wood et 
al. 2013; Bois et al. 2014). However, many imaging studies of UHR individuals have been 
cross-sectional in design and have therefore been limited in their ability to show 
developmental differences between UHR individuals with different outcomes. The 
longitudinal studies that have been conducted were only partially successful in predicting 
transition to psychosis and have reported many inconsistent findings (for review, see Wood 
et al. 2013). This may in part be related to limited follow-up times and differences in the 
methods used (Wood et al. 2013), but is likely also related to the diverse clinical outcomes 
of UHR individuals and the relatively arbitrary criterion of transition to psychosis (de Wit et 
al. 2014). One recent study of particular interest is that of Cropley and colleagues (2015): in 
subjects with attenuated positive symptoms, reduced grey matter volume was associated 
with more severe positive, negative and depressive symptoms and lower global functioning 
in the UHR subgroup without transition to psychosis. Unfortunately however, there is a lack 
of studies investigating brain development with MRI scans at different time points. 
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Therefore, we investigated brain development in resilient versus non-resilient UHR 
individuals over, on average, six years. We conducted a comprehensive assessment of 
symptoms and functioning and examined brain development, with MRI scans at three 
different time points. This study includes a long follow-up of six years and more than two 
MRI scans per individual. This permits a better assessment of outcome and non-linear 
modeling of developmental trajectories.  
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2. Methods and Materials 
2.1 Participants 
All data were collected at the Department of Psychiatry at the University Medical Center 
Utrecht, Brain Center Rudolf Magnus in the Netherlands. Participants were between 12 and 
18 years of age at the time of recruitment and were included after written informed 
consent. The study was approved by the Dutch Central Committee on Research Involving 
Human Subjects. 
Recruitment details have been described previously (Sprong et al. 2008; Ziermans et al. 
2011). Briefly, adolescents at UHR were referred by general practitioners or other psychiatry 
clinics. For inclusion at baseline, subjects in the UHR group had to fulfill at least one of the 
following criteria: 1) attenuated positive symptoms, 2) brief, limited, or intermittent 
psychotic symptoms, 3) genetic risk for psychosis combined with a deterioration in overall 
level of social, occupational/school, and psychological functioning in the past year or 4) two 
or more of nine basic symptoms of mild cognitive disturbances. The first three inclusion 
criteria were assessed using the Structured Interview for Prodromal Syndromes (McGlashan 
et al. 2001) and the Family Interview for Genetic Studies (Maxwell 1982). The fourth 
inclusion criterion was assessed using the Bonn Scale for the Assessment of Basic Symptoms-
Prediction List that was assessed by a clinical expert (TZ) working with child populations 
(Schultze-Lutter & Klosterkötter 2002). Exclusion criteria consisted of a past or present 
psychotic episode lasting more than one week, traumatic brain injury or any known 
neurological disorder, and verbal intellectual IQ < 75, as assessed using the Wechsler 
Intelligence Scales by one of the co-authors (TZ) as well as fully trained research assistants. 
(Wechsler 1997, 2002). The typically developing control group consisted of typically 
developing adolescents recruited through secondary schools in the region of Utrecht. They 
were excluded if they met one of the UHR-criteria, if they or any first degree relative had a 
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history of a psychiatric illness, or if they had a second-degree relative with a psychotic 
disorder.  
At baseline, 64 UHR individuals and 62 typically developing controls completed the clinical 
assessment and an MRI scan. These groups were then matched for gender, age, and number 
of follow-up scans, resulting in a longitudinal dataset of 48 UHR individuals and 48 typically 
developing controls with one, two or three scans and a total of 225 MRI scans. Participants 
were between 12,2 and 19,6 years of age at the time of the first MRI scan (Table 1). Follow-
up assessments were conducted 9 months, 18 months, 2 years, and 6 years post baseline 
(range 3,5-8,0 years). The follow-ups at 9 and 18 months only included clinical assessments. 
For an overview of the timeline, see Figure 1. We split the UHR group into two groups based 
on the 6-year clinical follow-up data, one ‘resilient’ and one ‘non-resilient’ subgroup. Clinical 
outcome was available for 35 UHR individuals at 6 year follow up. Resilience was defined by 
functional outcome using the modified Global Assessment of Functioning (mGAF) scale (Hall 
1995) as either a) Good functional outcome (resilient): mGAF score of ≥ 65 or b) Poor 
functional outcome (non-resilient): mGAF score of < 65. The cut off of 65 has been used 
before (Allen et al. 2014) and was chosen as the 60–70 range corresponds to ‘generally good 
function with meaningful interpersonal relationships, and some persistent mild symptoms 
and/or some persistent difficulty in social, occupational, or school functioning’ (Hall 1995). A 
score below 60 indicates ‘moderate to severe symptoms and/or moderate to severe 
difficulty in social, work, or school functioning,’ while scores above 70 correspond to ‘some 
transient mild symptoms to absent or minimal symptoms and/or slight to no impairment in 
social, work, or school functioning’. 
To make our results comparable to the existing literature we included an extra analysis in 
our supplemental material, where we used the “classic” operationalisation by McGlashan 
and colleagues based on UHR criteria (McGlashan et al. 2001), comparing individuals who 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 8 
had remitted from UHR criteria and individuals who had not. Further details on both 
subgroupings are provided in supplemental information S1. 
 
2.2 Image Acquisition  
MRI scans were acquired on a single 1.5-T scanner at all time points (Philips, Best, The 
Netherlands). Whole brain T1-weighted three-dimensional fast field echo scans were made 
with 1.5-mm contiguous coronal slices of the whole head (256 × 256 matrix, FoV = 256 mm, 
echo time (TE) = 4.6 ms, repetition time (TR) = 30 ms, flip angle = 30°).  
 
2.3 Image Processing 
Scans were processed and analyzed using FreeSurfer v 5.1.0 software. Technical details of 
the automated reconstruction scheme of this well-validated software program are described 
elsewhere (Dale et al. 1999; Fischl et al. 1999; Carmona et al. 2009). We calculated average 
volume (mm3), cortical thickness (mm), surface area (mm2), and gyrification for the 34 
cortical structures in each hemisphere from the Desikan-Killiany atlas (Desikan et al. 2006), 
as well as cortical thickness and surface area for each lobe and the whole brain, and total 
gray and white matter volume per hemisphere and the whole brain. Gyrification could not 
be estimated for 7 scans, because of FreeSurfer processing errors. We also measured the 
volume of subcortical structures, as well as subcortical gray matter volume and gray and 
white matter separately for the cerebellum. In order to reduce within-subject variability 
between scan sessions, the longitudinal analysis processing pipeline of FreeSurfer was used 
for subjects with more than one scan (Gogtay et al. 2006; Reuter & Fischl 2011). Manual 
edits were performed as necessary by a trained rater (SdW) blind to subject identity and 
group membership. 
 
2.4 Statistical Analyses 
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The statistical software package R version 2.14.0 was used (1) to test for between-group 
differences in the demographic and clinical data and (2) to investigate the effects of age, 
group and their interaction on the brain measures using a linear mixed model. The mixed 
model procedure investigated the relationship between age, group and our measures of 
interest (brain measures) using a top down selection procedure to test for the best-fit 
growth model. We were particularly interested in two effects: (1) main effects of group, 
where differences between groups were present at first assessment and stable over 
developmental time (range 12-24 years), and (2) group*age interaction effects where the 
developmental trajectories differed between the groups (e.g. structure X increased over 
time in group A while it decreased over time in group B). Details of this model and selection 
procedure are provided in supplemental information S2.  
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3. Results  
3.1 Between-group differences in demographic and clinical characteristics 
Demographic and clinical characteristics of typically developing controls and UHR individuals 
are provided in Table 1. Both groups were matched for age, gender and number of scans. 
Hand preference and intracranial volume did not differ between groups, but IQ was lower 
for UHR individuals than for typically developing controls.  
Demographic details of resilient and non-resilient individuals are given in Table 2. The 
subgroups did not differ in terms of the use of psychotropic medication (Table 2). Our 
definition of resilience largely overlaps with the definition as used in the classical definition 
based on remission of UHR symptoms (see Supplemental information S3 and S4): of 17 
individuals classified as resilient based on functional outcome, 12 were classified as being in 
remission; of 16 individuals classified being in remission, 12 were classified as resilient based 
on functional outcome. Of the five individuals classified as resilient based on functional 
outcome but not as being in remission, two had had a psychotic episode and later remitted 
with high mGAF scores at 6-year follow-up. The other three still scored in the UHR range for 
positive symptoms, but reported good functioning (mGAF scores between 70 and 80) at 6-
year follow-up. In clinical terms, resilience led to statistical improvements on symptom 
measures at follow-up, while there were few differences in symptoms at baseline. 
 
3.2 Brain development in UHR compared to typical development  
To allow comparison to earlier studies, we first tested for differences in brain development 
between the whole group of UHR individuals and typically developing controls. In the cortex, 
we found the largest differences in cortical surface area. Here, we primarily found 
group*age interactions, with less steep decreases over developmental time in UHR 
individuals in frontal and parietal areas compared to typically developing controls (p = 0.004 
– 0.043). We found fewer differences in cortical volume, cortical thickness and gyrification. 
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Furthermore, we found that UHR individuals showed stable as well as steeper decreases 
over developmental time in hippocampus (p = 0.012/0.006) and thalamus volume (p = 
0.015/0.022), as well as smaller volume at baseline and steeper increases over 
developmental time in the volume of third (p = 0.019) and inferior lateral ventricle (p = 
0.049) than typically developing controls. All results are listed in supplemental information 
S5.  
 
3.3 Brain development in resilient versus non-resilient UHR individuals  
Main effects of group and group*age interaction effects of resilient versus non-resilient 
individuals are shown in Figure 2 and listed in supplemental information S6. We additionally 
provided results from the analyses using the classic operationalisation (remission from UHR 
criteria) in supplemental information S7. These were highly similar to those reported in the 
main paper.  
  3.3.1. Stable differences between groups  
There were widespread differences between resilient and non-resilient UHR individuals that 
were stable over developmental time (i.e., main effects of group). Resilient individuals had 
larger volumes of frontal, temporal and parietal cortex, corpus callosum and nucleus 
accumbens than non-resilient individuals (p = 0.003 – 0.025, see supplemental information 
S4). Furthermore, overall cortical thickness was larger for resilient compared to non-resilient 
individuals, mainly due to increases in thickness in frontal, parietal and temporal lobes (p = 
0.000 – 0.046). Cortical surface area was larger throughout the left hemisphere and there 
were some differences in gyrification (p = 0.003 – 0.042) see supplemental information S4). 
When we added the trajectories of typically developing controls in these areas, we found 
that they fell between those of resilient and non-resilient individuals. This is illustrated in the 
supplemental information where some of the graphs of these trajectories are provided (S8).  
  3.3.2 Developmental differences   
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There were some developmental differences between resilient and non-resilient UHR 
individuals where developmental trajectories diverged between groups over time 
(group*age interactions; see Figure 3). Resilient individuals showed smaller decrease in 
volume over developmental time in anterior cingulate gyrus (p = 0.049) and smaller increase 
over developmental time in lateral ventricle volume (p = 0.036). Furthermore, resilient 
individuals showed greater decreases in cortical thickness in superior temporal cortex (p = 
0.038) and posterior cingulate gyrus (p = 0.011) than non-resilient individuals. Resilient 
individuals also showed increases over developmental time in cortical surface area in 
precentral gyrus (p = 0.037) and frontal pole (p = 0.033) compared to decreases in non-
resilient individuals. Finally, resilient individuals showed decreases in gyrification in anterior 
cingulate gyrus over developmental time compared to increases in non-resilient individuals 
(p = 0.049). 
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4. Discussion  
We investigated brain development over six years in a matched sample of 48 adolescents at 
ultra-high risk for developing psychosis and 48 typically developing controls, with up to three 
MRI scans per individual. Our main goal was to compare brain development between 
resilient and non-resilient UHR individuals. We operationalized resilience as good 
functioning at 6-year follow-up, information that was available for 35 of the UHR individuals. 
We found widespread differences in volume of frontal, temporal and parietal cortex that 
were already present at baseline and remained stable over development. Furthermore, 
there were differences between resilient and non-resilient individuals in the development of 
cortical surface area in multiple frontal regions including cingulate gyrus. These diverging 
developmental trajectories may reflect compensatory neural mechanisms, where the better 
functioning resilient individuals results in less tissue loss with development.  
 
When we compared brain development between all UHR individuals and typically 
developing volunteers, we found diverging developmental trajectories for cortical surface 
area in frontal and parietal regions. Here, typically developing controls showed greater 
decreases over development than UHR individuals. Furthermore, we found decreases in 
hippocampus and thalamus volume and increases in the volume of the third and inferior 
lateral ventricles in UHR individuals that were already present at baseline. These findings are 
in keeping with other studies on psychosis and UHR (for reviews, see Fusar-Poli et al. 2011, 
2012b; Wood et al. 2013; Bois et al. 2014).  
 
When we compared brain development between resilient and non-resilient UHR individuals, 
we found three types of changes: First, there were differences that were already present at 
baseline and that were stable over development, with the developmental trajectories 
parallel for both groups. These included greater cortical thickness and cortical volume and 
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larger volume of the nucleus accumbens and corpus callosum in resilient individuals. 
Interestingly, when we added the trajectories of typically developing controls in these areas, 
we found that they fell between those of resilient and non-resilient individuals (see 
supplemental information S6). As such, the volume of resilient individuals exceeded that of 
typically developing volunteers, one possible mechanism that may be at play is that the 
greater volume may be protective for worse outcome, including less tissue loss. In addition, 
these volumetric differences might be a predictive marker of good outcome. Earlier 
longitudinal studies of development in UHR individuals primarily focused on transition to 
psychosis. Most of these have shown differences between UHR individuals with different 
clinical outcomes in insular, temporal, parietal and superior frontal regions (Fornito et al. 
2008; Sun et al. 2009; Ziermans et al. 2012; Wood et al. 2013). One study investigated 
differences in baseline grey matter volume between non-transitioned individuals with and 
without persistent attenuated positive symptoms and found differences in frontal, temporal, 
posterior and cingulate regions (Cropley et al. 2015). These regions highly overlap with our 
results. Our data suggest that these regions may hold promise for predicting, at a young age, 
which UHR individuals will get better and which will worsen over time. This was also 
suggested by Cropley and colleagues ( 2015).   
A second pattern in our data is developmental trajectories that overlap at young age but 
diverge over developmental time. Areas showing this pattern include precentral gyrus, 
frontal pole, anterior cingulate gyrus and lateral ventricle (see Figure 3). The enlargement of 
lateral ventricles was one of the first brain findings to be reported in schizophrenia and is 
still one of the most consistently reported (Shenton et al. 2001). In our study, the volume of 
lateral ventricles increased more over development for non-resilient individuals than for 
resilient ones. The anterior cingulate gyrus showed decreases in volume over development 
for both resilient and non-resilient individuals. However, its volume stabilized in early 
adulthood for resilient individuals, whereas it continued to decrease in the non-resilient 
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group. This structure is important for goal-directed behavior and involved in error and 
conflict monitoring and has often been reported to show changes in structure and function 
in UHR and schizophrenia (Fornito et al. 2008, 2009; Reid et al. 2010). The stabilization in the 
resilient group may reflect neural changes as a result of recovery in this group, whereas the 
continuing loss of volume in non-resilient individuals may reflect their continuing difficulties 
with cognitive and emotional integration (Fornito et al. 2008, 2009). The left precentral 
gyrus and right frontal pole showed developmental increases in surface area in resilient 
individuals compared to slight decreases in non-resilient individuals. Changes in frontal areas 
have often been associated with UHR and schizophrenia (for review, see Wood et al. 2013). 
As such, these increases may also represent compensatory mechanisms, related to better 
functioning in resilience. Other structures, such as the posterior cingulate and superior 
temporal gyrus, showed converging trajectories, where baseline differences disappeared 
with development. Interestingly, both resilient and non-resilient individuals showed 
decreases over development in cortical thickness in these areas, similar to what is seen in 
typical development. However, the non-resilient group showed a slower rate of change than 
the resilient group. These findings concur with a study by Zalesky and colleagues ( 2015): 
these authors reported maturational delays in cortical thickness in childhood onset 
schizophrenia, and normalization of these changes over development for those subjects who 
showed symptomatic improvement. 
Finally, there were brain areas that differed between UHR individuals and typically 
developing controls, but not between resilient and non-resilient UHR individuals. These 
included hippocampus, thalamus and frontal and parietal cortical surface area. These 
changes are unlikely to be useful for predicting long-term functioning in UHR individuals, as 
they do not differ between resilient and non-resilient individuals. Rather, they may be 
related to non-specific UHR risk factors, such as obstetric complications (Stefanis et al. 1999; 
Wood et al. 2008). 
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In our supplemental materials, we have included the results of a second analysis where we 
compared those UHR individuals who had remitted from their UHR status to those who had 
not. The results from this analysis were similar but noisier (see supplemental information 
S7). The biggest difference was found for gyrification: while there were few differences in 
gyrification found with the operationalisation based on functional outcome, more were 
found with the analysis using remission from UHR criteria. This might suggest that 
differences in gyrification are more specific to positive symptoms than global functioning. 
We chose to present the results from the operationalisation based on functional outcome as 
we felt that was the definition with the most clinical relevance. Hence, when interpreting 
the results, we should keep in mind that the main findings of this paper relate to global 
functioning.   
 
There are some limitations to this study. First is the relatively modest sample size, especially 
for the follow-up analyses on resilience (17 versus 18 subjects). This is in part because it was 
necessary to exclude some subjects from these analyses to match subgroups for gender and 
age. We felt it was important to maintain this matching given the skewed distribution of 
gender in UHR and schizophrenia (McGrath et al. 2008; Walder et al. 2013; Cocchi et al. 
2014) and findings of gender differences in brain size and development (Lenroot et al. 2007; 
Wierenga et al. 2014). The limited sample size means we may have been underpowered to 
detect subtle differences, and may be causal to the relatively small number of 
developmental changes found. On the other hand, longitudinal samples require far fewer 
participants than cross-sectional studies in order to detect small differences in brain 
structure. Steen and colleagues showed that the required sample to detect a 5% difference 
in whole brain volume is 73 patients and 73 typically developing controls in a 2-sample 
cross-sectional study, against just 5 patients and 5 typically developing controls in a 
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longitudinal study design (Steen et al.). Moreover, we were able to report longitudinal data 
with more than two MRI scans per individual, potentially permitting us to fit more complex 
developmental models to the data.  
A second limitation is that a large number of UHR individuals were on medication for the 
duration of this study. This is often the case in UHR studies and one can argue that 
medication may have been prescribed for individuals who were clinically more severely 
affected, or that it may have helped prevent the onset of psychosis. However, medication 
use did not differ between resilient and non-resilient individuals, not at baseline or at 
follow-up. This suggests that medication use did not overly influence our results. The lack of 
a difference between resilient and non-resilient individuals could even be taken to suggest 
that medication does not play a role in individual outcome, although the sample size is too 
modest to permit any such definitive conclusion.  
 
In conclusion, brain development in resilient individuals initially at UHR for psychosis differs 
from that of non-resilient individuals. Widespread differences in cortical thickness and 
volume were evident at baseline and remained stable over development. However, several 
frontal areas showed diverging developmental trajectories. The stable differences that were 
already present at baseline may hold promise for predicting, at a young age, who will go on 
to recover and who will not, whereas the divergence in frontal areas may reflect neural 
changes related to better functioning. 
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Figure legends 
Figure 1: Timeline of the study. The top bar shows the time points at which individuals had a 
clinical assessment and/or MRI scanning session, at 0, 9, 18, 24 and 72 months follow-up. 
The number of individuals included at baseline and follow up are displayed for the typical 
developing control group (middle) and UHR individuals (bottom). At six-year follow up, 17 
individuals were defined as resilient and 18 individuals as non-resilient.  
Figure 2: Differences in cortical morphology between resilient and non-resilient UHR 
individuals  
Figure 3: Distinct developmental trajectories between resilient and non-resilient UHR 
individuals  
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Table 1. Demographic data for typically developing controls (TDC) and UHR individuals 
 TDC UHR UHR vs. TDC 
Number of individuals, n (males) 48 (29) 48 (29) n.s. 
Hand preference, n, right/non-right 40/8 44/4 n.s. 
Parental education, years, mean (SD)    
    Mother 13.45 (2.39) 12.96 (2.16) n.s. 
    Father 14.22 (2.17) 13.74 (2.18) n.s. 
Premorbid IQ, mean (SD) 107.04 (13.12) 100.40 (11.97) t = 2.85, p = 0.01 
Age at baseline scan, years    
    Mean (SD) 15.72 (1.54) 15.43 (2.11) n.s. 
    Range 12.19-18.76 12.28-19.64  
Age at 6-year FU scan, years    
    Mean (SD) 21.40 (1.57) 21.16 (2.42) n.s. 
    Range 17.57-24.54 16.84-25.79  
Intra Cranial Volume (mm
3
) 1621000 (148220) 1586000 (167740) n.s. 
Number of scans, n   n.a. 
     Total number of scans, n 103 122  
     1 48 48  
     2 24 39  
     3 31 35  
Notes: TDC = typically developing controls; UHR = Individuals at ultra-high risk for psychosis; IQ = 
intelligence quotient; SD = standard deviation; FU = follow-up  
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Table 2. Demographic and clinical data of resilient (R) and non-resilient (NON-R) UHR individuals 
based  
on functional outcome
a 
 
  
                   R        NON-R  R vs. NON-R 
Number of individuals, n (males) 17 (13) 18 (10) n.s. 
Premorbid IQ, mean (SD) 101.18 (12.89) 103.22 (10.28) n.s. 
Age at baseline, years    
    Mean (SD) 15.42 (2.20) 15.54 (2.48) n.s. 
    Range 12.31 - 19.64 12.28 - 19.43  
Age at 6-year FU, years    
    Mean (SD) 21.34 (2.58) 20.99 (2.32) n.s. 
    Range 17.88 - 25.79 16.84-24.80  
SIPS/SOPS baseline, mean (SD)    
    Total score 21.35 (10.74) 25.06 (11.47) n.s. 
    Positive symptoms 7.41 (4.53) 8.50 (3.13) n.s. 
    Negative symptoms 4.24 (4.66) 4.17 (3.67) n.s. 
    Disorganized symptoms 3.41 (3.30) 5.89 (2.83) U = 68.0, p = 0.004 
    General symptoms 6.29 (4.33) 6.50 (4.51) n.s. 
mGAF baseline, mean (SD) 57.06 (13.57) 56.83 (17.44) n.s. 
SIPS/SOPS 6-year FU, mean (SD)    
    Total score 11.75 (8.36) 35.11 (14.11) U = 20.5, p = <0.001 
    Positive symptoms 3.88 (3.59) 10.00 (5.54) U = 45.5, p = <0.001 
    Negative symptoms 3.88 (3.72) 11.17 (5.79) U = 44.0, p = <0.001 
    Disorganized symptoms 3.19 (2.74) 7.22 (3.37) t = 3.80, p = 0.001 
    General symptoms 1.50 (1.59) 6.72 (4.86) U = 42.0, p = <0.001 
mGAF 6-year FU, mean (SD) 77.94 (7.30) 47.50 (9.94) t = -10.27, p = <0.001 
Psychotropic medication baseline, any   n.s. 
    No 9 9  
    Yes 8 9  
Psychotropic medication 6-year FU, any   n.s. 
    No 13 11  
    Yes 4 7  
 
Notes: 
a
 Subgroups are based on outcome at 6-year FU; outcome was unknown for 13 UHR individuals  
TDC = typically developing controls; UHR = Individuals at ultra-high risk for psychosis; R = resilience;  
NON-R = non-resilience; IQ = intelligence quotient;  SD = standard deviation; FU = follow-up; 
SIPS/SOPS =  
Structured Interview for Prodromal Symptoms / Scale of Prodromal Symptoms; mGAF = Modified 
Global  
Assessment of Functioning 
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Highlights 
 Is brain development different between resilient and non-resilient UHR individuals? 
 We performed a longitudinal MRI study with up to three scans per individual. 
 Resilience was defined by functional outcome at 6-year follow-up.  
 Widespread differences were found, primarily in volume and cortical surface area. 
 Developmental differences may reflect compensatory neural mechanisms. 
